Related Articles
DR2 blocker thioridazine: A promising drug for ovarian cancer therapy Corrigendum in /10.3892/ol.2020.11285
Carnosic acid and fisetin combination therapy enhances inhibition of lung cancer through apoptosis induction
Fisetin inhibits pristine-induced systemic lupus erythematosus in a murine model through CXCLs regulation
Anti‑cancer effects of fisetin on mammary carcinoma cells via regulation of the PI3K/Akt/mTOR pathway: In vitro and in vivo studies
Downregulation of drs mRNA expression is associated with the progression of adult T-cell leukemia/lymphoma